Real-World Effectiveness And Safety Of Upadacitinib For The Treatment Of Moderate To Severe Crohn’s Disease In A Belgian Multi-Centric Refractory Cohort

Pavlidi, Anastasia; Verstockt, Bram; Lobaton Ortega, Triana; Vieujean, Sophie; Baert, Filip; Dewit, Olivier; Rahier, Jean François; Ouziel, Romy; Hoyois, Alice; Holvoet, Tom; Couturier, Filip; Willandt, Barbara; Bossuyt, Peter; Somers, Michaël; Salame, Mikhaël; Verreth, Annelies; Franchimont, Denis; Cremer, Anneline

Poster (Scientific congresses and symposiums)

Pavlidi, Anastasia; Verstockt, Bram; Lobaton Ortega, Triana et al.

2024 • UEG Week Vienna 2024

Peer reviewed

Permalink
https://hdl.handle.net/2268/325822

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

MP328.pdf

Author postprint (635.21 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Gastroenterology & hepatology

Author, co-author :

Pavlidi, Anastasia

Verstockt, Bram

Lobaton Ortega, Triana

Vieujean, Sophie ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive

Baert, Filip

Dewit, Olivier

Rahier, Jean François

Ouziel, Romy

Hoyois, Alice

Holvoet, Tom

More authors (8 more)

Language :

English

Title :

Real-World Effectiveness And Safety Of Upadacitinib For The Treatment Of Moderate To Severe Crohn’s Disease In A Belgian Multi-Centric Refractory Cohort

Publication date :

12 October 2024

Event name :

UEG Week Vienna 2024

Event place :

Vienna, Austria

Event date :

October 12-15, 2024

By request :

Yes

Audience :

International

Peer reviewed :

Peer reviewed

Available on ORBi :

since 24 December 2024

Statistics

Number of views

15 (1 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics